SRXH
SRx Health Solutions Inc.
NYSE MKT: SRXH · CONSUMER DEFENSIVE · PACKAGED FOODS
$0.11
-0.52% today
Updated 2026-04-29
Market cap
$55.45M
P/E ratio
—
P/S ratio
5.94x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$0 – $2
Volume
25.4M
SRx Health Solutions Inc. (SRXH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $42.59M | $46.01M | $92.63M | $118.94M | $34.98M | $6.53M |
| Revenue growth (YoY) | — | +8.0% | +101.3% | +28.4% | -70.6% | -81.3% |
| Cost of revenue | $28.24M | $32.30M | $79.33M | $95.33M | $22.12M | $5.04M |
| Gross profit | $14.35M | $13.70M | $13.31M | $23.61M | $12.86M | $1.50M |
| Gross margin | 33.7% | 29.8% | 14.4% | 19.9% | 36.8% | 22.9% |
| R&D | — | — | — | — | $100000.00 | — |
| SG&A | — | — | $13.14M | $26.55M | $0.00 | $12.93M |
| Operating income | $-27.32M | $-17.28M | $-1.17M | $-5.81M | $-5.97M | $-11.53M |
| Operating margin | -64.2% | -37.6% | -1.3% | -4.9% | -17.1% | -176.5% |
| EBITDA | $-48.34M | $8.30M | $-539401.00 | $-7.05M | $438000.00 | $-11.50M |
| EBITDA margin | -113.5% | 18.1% | -0.6% | -5.9% | 1.3% | -176.0% |
| EBIT | $-50.09M | $6.64M | $-1.17M | $-8.76M | $308000.00 | $-11.53M |
| Interest expense | $9.25M | $3.22M | $753714.00 | $2.05M | $467000.00 | $875890.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-59.34M | $2.98M | $-2.45M | $-11.14M | $-168000.00 | $-45.01M |
| Net income growth (YoY) | — | +105.0% | -182.1% | -354.7% | +98.5% | -26689.3% |
| Profit margin | -139.3% | 6.5% | -2.6% | -9.4% | -0.5% | -688.8% |